 AXISCADES Technologies Ltd. and Cilas S.A. announce Strategic Defense Partnership
AXISCADES Technologies Ltd. and Cilas S.A. announce Strategic Defense Partnership Svitzer and Cochin Shipyard Ltd. sign LoI to advance electric TRAnsverse tug manufacturing in India
Svitzer and Cochin Shipyard Ltd. sign LoI to advance electric TRAnsverse tug manufacturing in India RailTel Corporation of India Ltd receives order from Defence Customer
RailTel Corporation of India Ltd receives order from Defence Customer L&T and GA-ASI Announce Strategic Partnership for MALE RPAS Manufacture in India
L&T and GA-ASI Announce Strategic Partnership for MALE RPAS Manufacture in India NATCO announces launch of its Everolimus tablets, 1 mg, (generic of Zortress®)
NATCO announces launch of its Everolimus tablets, 1 mg, (generic of Zortress®) 
              The Initial Public Offering (IPO) of Claris Lifesciences Limited will open for subscription by investors on November 24, 2010. The company is coming out with public issue of equity shares of Rs.10 each for cash aggregating to Rs.300 crores.
The 100% book building issue is priced in a price band of Rs.278 to Rs.293. The Minimum Order Quantity is 22 Equity Shares and in multiples of 22 Equity Shares. The Maximum Subscription Amount for Retail Investor is Rs.200000.
The Rating Agency Fitch Ratings India Private Limited has assigned IPO Grading of IPO Grade 3.
Enam Securities Private Limited, Edelweiss Capital Limited, JM Financial Consultants Private Limited and ICICI Securities Limited are the Book Running Lead Managers to the IPO. Edelweiss Securities Limited and JM Financial Services Private Limited are the Syndicate Members to the IPO.
Link Intime India Private Limited is the registrar to the company.
The IPO closes for subscription on November 26, 2010.